Cytogenetic Studies in the Neonatal Period

 

Reviewed by Julie McGaughran
January
2001
Clinical Guidelines Back Newborn Services Home Page

Note: Given the increasing concerns around genetic testing without informed consent, only tests for diagnostic or management reasons should be carried out in the neonatal period.

Cord Blood

  • Confirmation of suspected chromosomal disorder following abnormal antenatal ultrasound undertaken late in pregnancy or where further investigation declined during in the pregnancy.
  • Chromosome mosaicism found at CVS, amniocentesis or cordocentesis (where indicated)
  • DNA studies. Cord blood confirmation of single gene disorder suspected on ultrasound findings eg achondroplasia
    Testing for late onset disorders should not be undertaken
  • Confirmation of biochemistry where prenatal diagnosis of a known condition undertaken (requested by testing lab)

Neonatal Testing

  • Blood
  1. Clinical features consistent with known chromosomal abnormality.
  2. Multiple congenital anomalies consistent with possible chromosomal abnormality
  3. FISH; where range of clinical features suggests a specific microdeletion syndrome, specific FISH test should be requested.
  4. Ambiguous genitalia.
  • Solid Tissues
  1. Products of conception.
  2. Post mortem - (1) - (4) as above.

Guidelines for DNA Studies in the Neonatal Period

  • Features of a single gene disorder/syndrome (for diagnostic purposes) e.g. hypotonia
  • Mitochondrial myopathy syndrome.
  • Features of possible single gene disorder where infant may die and genetic testing may later become available (DNA storage)

Blood Collection Tubes